B
Bailard Portfolio holdings
AUM
$4.29B
This Quarter Return
+21.06%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$1.79B
AUM Growth
+$1.79B
(+27%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
7.09%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
575
New
129
Increased
174
Reduced
152
Closed
75
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$49.8M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$41.8M |
| 3 |
iShares National Muni Bond ETF
MUB
|
$10.7M |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
$4.45M |
| 5 |
L3Harris
LHX
|
$4.12M |
Top Sells
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
$5.76M |
| 2 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
$4.69M |
| 3 |
Gilead Sciences
GILD
|
$4.57M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.47M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$4.41M |
Sector Composition
| 1 | Technology | 16.8% |
| 2 | Healthcare | 8.12% |
| 3 | Financials | 4.94% |
| 4 | Communication Services | 4.63% |
| 5 | Consumer Discretionary | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Starbucks
SBUX
$99.2B
| $5.06M | 0.28% |
68,801
+617
| +0.9% | +$45.4K |
|
77
Esperion Therapeutics
ESPR
$490M
| $5.05M | 0.28% |
98,500
+5,200
| +6% | +$267K |
|
78
Bank of America
BAC
$371B
| $4.88M | 0.27% |
205,441
+40,357
| +24% | +$958K |
|
79
CVS Health
CVS
$93B
| $4.8M | 0.27% |
73,897
+6,457
| +10% | +$420K |
|
80
PNC Financial Services
PNC
$80.7B
| $4.78M | 0.27% |
45,448
+2,332
| +5% | +$245K |
|
81
Cummins
CMI
$54B
| $4.63M | 0.26% |
26,720
+2,381
| +10% | +$413K |
|
82
Sprott Physical Gold
PHYS
$12.7B
| $4.54M | 0.25% |
317,359
| – | – |
|
83
Quest Diagnostics
DGX
$20.1B
| $4.48M | 0.25% |
39,291
+3,995
| +11% | +$455K |
|
84
Mersana Therapeutics
MRSN
$34.8M
| $4.47M | 0.25% |
191,000
+46,000
| +32% | +$1.08M |
|
85
iShares Global REIT ETF
REET
$3.94B
| $4.3M | 0.24% |
205,873
+104,955
| +104% | +$2.19M |
|
86
Qualcomm
QCOM
$170B
| $4.17M | 0.23% |
45,733
+5,677
| +14% | +$518K |
|
|
87
L3Harris
LHX
$51.1B
| $4.12M | 0.23% |
+24,296
| New | +$4.12M |
|
88
Teva Pharmaceuticals
TEVA
$21.5B
| $4.09M | 0.23% |
+332,000
| New | +$4.09M |
|
89
Linde
LIN
$221B
| $4.09M | 0.23% |
19,299
+1,622
| +9% | +$344K |
|
90
Lam Research
LRCX
$124B
| $4.04M | 0.23% |
12,498
+1,766
| +16% | +$571K |
|
91
Vanguard Consumer Staples ETF
VDC
$7.61B
| $3.94M | 0.22% |
26,328
-3,497
| -12% | -$523K |
|
92
Booz Allen Hamilton
BAH
$13.2B
| $3.89M | 0.22% |
49,949
+13,549
| +37% | +$1.05M |
|
93
ASML
ASML
$290B
| $3.73M | 0.21% |
10,126
+2,980
| +42% | +$1.1M |
|
94
Sangamo Therapeutics
SGMO
$161M
| $3.63M | 0.2% |
405,000
-46,000
| -10% | -$412K |
|
|
ITCI
95
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.62M | 0.2% |
+141,000
| New | +$3.62M |
|
96
iShares MSCI EAFE ETF
EFA
$65.4B
| $3.57M | 0.2% |
58,707
+6,084
| +12% | +$370K |
|
97
Trane Technologies
TT
$90.9B
| $3.52M | 0.2% |
39,536
+973
| +3% | +$86.6K |
|
98
iShares S&P 500 Value ETF
IVE
$40.9B
| $3.47M | 0.19% |
32,055
+752
| +2% | +$81.4K |
|
99
iShares S&P 500 Growth ETF
IVW
$63.2B
| $3.47M | 0.19% |
16,709
-60
| -0.4% | -$12.5K |
|
100
Sony
SONY
$162B
| $3.47M | 0.19% |
50,137
+107
| +0.2% | +$7.4K |
|